DNA ASSET MANAGEMENT PTY LTD – Trademark Portfolio
Entity Type: 99
DNA ASSET MANAGEMENT PTY LTD holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include PROUDI and YUMGUARD.
PO BOX 886
Showing of trademarks Trademarks
Trademark Classifications
DNA ASSET MANAGEMENT PTY LTD's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does DNA ASSET MANAGEMENT PTY LTD have?
DNA ASSET MANAGEMENT PTY LTD has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does DNA ASSET MANAGEMENT PTY LTD file in?
DNA ASSET MANAGEMENT PTY LTD files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are DNA ASSET MANAGEMENT PTY LTD's most well-known trademarks?
DNA ASSET MANAGEMENT PTY LTD's registered trademark portfolio includes well-known marks such as PROUDI and YUMGUARD. These are among 4 currently registered trademarks in the portfolio.
What is DNA ASSET MANAGEMENT PTY LTD's trademark registration success rate?
DNA ASSET MANAGEMENT PTY LTD has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.